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Abstract
Objective—To determine if the molecular profiles of endometriotic lesions contain informative 
measures of inflammation and immune dysfunction that may contribute to better understanding of 
the interplay between immune dysfunction and inflammation and their contribution to 
endometriosis pathogenesis.
Design—Immune and inflammation transcriptomic analysis with the use of the Nanostring 
nCounter GX Human Immunology V2 platform (579 human immune and inflammation–related 
genes and 15 housekeeping genes).
Setting—Academic university and teaching hospital.
Intervention(s)—None.
Patient(s)—Stage III–IV endometriosis patients with infertility (n = 8) and fertile disease-free 
control women undergoing tubal ligation (n = 8). Menstrual stage was matched to secretory phase 
in all participants.
Main Outcome Measure(s)—Immune and inflammation transcriptomics quantification from 
ectopic endometriotic lesions and matched eutopic endometrium from patients. Endometria of 
fertile women served as control subjects.
Result(s)—Our results displayed endometriotic lesions as molecularly distinct entities compared 
with eutopic endometrium and endometrium of control samples; 396 out of 579 screened immune 
and inflammation–related genes were significantly different in ectopic tissues compared with 
control endometrium. Most importantly, eutopic endometrium of the patients displayed a unique 
molecular profile compared with the control endometrium (91/579 genes were significantly 
different), particularly of genes involved in regulation of cell apoptosis and decidualization.
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Conclusion(s)—We characterize differential expression of immune-inflammation genes in 
endometriosis patients, and show molecular distinction of eutopic endometrium of patients 
compared with control fertile women.
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Endometriosis is a disease driven by the inflammatory peritoneal environment (1, 2). 
Characterized by the growth of endometrial-like tissue in ectopic locations, endometriosis 
affects millions of women worldwide with chronic pelvic pain and subfertility (3). Despite 
decades of research, pathogenesis of endometriosis is incompletely understood, and multiple 
theories exist regarding its etiology (4). Since Sampson’s theory of retrograde menstruation, 
which proposed endometrial fragments as the potential source of endometriosis (5), 
numerous studies have documented the high prevalence of retrograde menstruation in 
women with endometriosis (6). However, that theory does not adequately explain disease 
prevalence, because women with and without endometriosis commonly demonstrate 
retrograde menstruation (7, 8), but the disease is present in only 2%–10% of women (9). 
Indeed, dysregulation of the immune response toward endometriotic lesions has been noted 
in patients, including increased inflammatory cytokines and overreactive macrophages and 
neutrophils in the peritoneal cavity (10, 11). Additionally, autoimmune diseases are 
commonly diagnosed in endometriosis patients (12), which further strengthens the notion of 
dysfunctional immune regulation in women with endometriosis. To provide improved 
therapeutic options and to increase the diagnostic power of this detrimental disease, it is 
imperative that we attempt to dissect the molecular profile of endometriosis pathogenesis 
(13). To this end, we hypothesized that endometriotic lesions have a distinct molecular 
profile that will provide insights into biologic mechanisms and pathways that govern the 
immune dysfunction and inflammation in women with endometriosis.
In this study, we profiled the expression of 579 genes involved in immunology and 
inflammation with the use of the nCounter GX Human Immunology v2 Kit (Nanostring 
Technologies), from three tissue sources: pelvic endometriotic lesions, matched eutopic 
endometrium from the patients, and endometrium samples from fertile (disease-free) women 
as control samples. All of our samples were matched to the secretory phase of the menstrual 
cycle. To our knowledge, this study is the first to attempt molecular profiling of differential 
immune and inflammation gene expression between matched ectopic tissues and eutopic 
endometrium from patients, ectopic and control endometrium, and eutopic and control 
endometrium that are also matched by menstrual cycle. Our results demonstrate 
dysregulation of a number of specific pathways involving leukocyte activation and cytokine-
cytokine receptor interaction in endometriosis samples. In addition, our data provides 
insights into immune gene expression profile of eutopic endometrium of women with 
endometriosis compared with control endometrium samples.
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MATERIALS AND METHODS
Ethics Approval
Human eutopic endometrial and ectopic endometriosis tissue samples were collected from 
endometriosis patients, and endometrial samples were collected from control subjects 
comprising healthy women after informed consent with the use of a protocol approved by 
the Institutional Review Committees at Greenville Health Systems, Greenville, South 
Carolina, and the University of North Carolina, Chapel Hill, North Carolina. Ethics approval 
for this study was provided by the Health Sciences Research Ethics Board, Queen's 
University, Kingston, Ontario, Canada.
Sample Collection from Patients and Control Women Undergoing Laparoscopic Surgery
Matched human endometrium (n = 8) and endometriosis samples (n = 8) from patients with 
stage III–IV endometriosis were provided by Greenville Hospital Systems, Greenville, South 
Carolina, after informed consent from patients. The mean age and body mass index (BMI) of 
the patient group were 33.1 ± 7.3 years and 24.2 ± 4.0 kg/m2, respectively. Out of the eight 
patients, four patients were nulligravida, three were primigravida, and one was multigravida. 
The stage of endometriosis was determined based on the revised American Society of 
Reproductive Medicine criteria (14). From each endometriosis patient undergoing 
laparoscopic removal of the disease, the eutopic endometrium samples were obtained by 
means of Pipelle sampling. The patient samples used in this study comprised women 
diagnosed with infertility and/or pelvic pain, and all of the women, including patients and 
fertile control subjects, were free from hormonal therapy for 3 months before the collection 
of samples. For control samples, endometrial biopsies (n = 8) were obtained by means of 
Pipelle sampling from healthy fertile women who underwent tubal ligation at the University 
of North Carolina. The mean age and BMI of the control group were 26 ± 5.8 years and 23.4 
± 2.6 kg/m2, respectively. All eight healthy control subjects had no history of pregnancy. All 
samples were snap-frozen with the use of liquid nitrogen and then stored at −80°C until 
further use. All patients and healthy control subjects were at the secretory phase of the 
menstrual cycle when samples were obtained.
Gene Expression Profiling with the Use of Nanostring nCounter GX Human Immunology v2 
Kit
Total RNA was isolated from all samples with the use of Norgen Biotek Total RNA isolation 
kit (no. 17200) per the manufacturer’s instructions. In brief, tissues were homogenized in 
600 µL lysate buffer by means of an electrical mortar and pestle and then were centrifuged at 
15,000 rpm for 1 minute at 20°C. The resulting supernate was collected, mixed with 70% 
ethanol, and passed through the columns provided with the kit. The concentration and 
quality of RNA from each sample was assessed with the use of a Nanodrop 2000 
Spectrophotometer (Thermo Scientific). All samples were normalized to 25–30 ng/µL with 
the use of RNAse-free distilled water. Nanostring nCounter analysis system–based gene 
expression profiling was performed on 100 ng total RNA from each sample as previously 
reported (15). Briefly. All RNA samples were subjected to analysis by means of nCounter 
Human Immunology v2 Panel consisting of 579 immune and inflammation–associated 
genes and 15 housekeeping genes as control samples in a prebuilt panel. The samples were 
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subjected to overnight hybridization reaction at 65°C, where 5 µL of total RNA samples 
were combined with 20 µL of nCounter Reporter probes in hybridization buffer and 5 µL 
nCounter capture probes for a total reaction volume of 30 µL. Post-hybridization of probes 
with targets of interest in the samples, the abundance of target molecules, was quantified 
with the use of the nCounter Digital Analyzer and assessed with the use of the nSolver 
platform.
Statistical Analysis, Marker Selection Analysis, and Hierarchic Clustering with the Use of 
GENE-E Software
The nCounter human Immunology v2 panel included 15 housekeeping genes, eight negative 
and six positive control samples, that were used for background subtraction and 
normalization of the raw mRNA transcript counts of all samples. With the use of nSolver 
data analysis software provided by Nanostring technologies, the raw data were normalized 
with the use of the geomean of all six positive control samples, in addition to the geomean of 
the housekeeping genes that displayed percentage coefficient of variation (%CV) of ≤55. 
The list of ten housekeeping genes used in the normalization process is shown in 
Supplemental Table 1 (Supplemental Tables 1–6 and Supplemental Figs. 1–7 are available 
online at www.fertstert.org). After normalization and background noise subtraction with the 
use of in-house negative control samples, the data were transferred into Graphpad Prism to 
perform multiple t tests with correction for multiple comparisons by means of the Holm-
Sidak method. For multiple t tests, alpha was set to 0.05. We further selected the 299 genes 
that were significantly differentially expressed between the comparisons of ectopic versus 
control and ectopic versus eutopic and attributed them to be ectopic-specific genes. 
Additionally, the 299 genes were ranked by signal-to-noise ratio by means of marker 
selection analysis provided by GENE-E (www.broadinstitute.org/cancer/software/GENE-
E/). Heat maps for visualization of differential gene expression patterns for the comparisons 
of ectopic versus control, ectopic versus eutopic, and eutopic versus control were also 
generated for all 579 genes (Supplemental Fig. 1). We used DAVID bioinformatics resources 
6.7 (https://david.ncifcrf.gov/) for KEGG pathway analysis and Gene Ontology (GO) terms. 
Series of two-tailed paired (ectopic vs. eutopic) or nonpaired (ectopic vs. control, eutopic vs. 
control) t tests were also performed on genes that showed statistical significance from 
multiple t tests. Outlier identifying test was conducted on comparisons of ectopic versus 
control, ectopic versus eutopic, and eutopic versus control, which was followed by 
nonparametric t test (Mann-Whitney U test) after removal of the identified outliers with the 
use of Graphpad Prism. Nonparametric Wilcoxon signed rank test was performed on 
comparisons of ectopic versus eutopic. A two-tailed P value of ≤.05 was considered to be 
statistically significant on the t tests. Fold difference of >1.5 was considered to have biologic 
significance and was taken into account when analyzing the data.
RESULTS
By means of the relatively novel method of quantifying transcriptomics with minimal 
sample manipulation, our study set out to investigate the differential gene transcript counts 
from matched ectopic endometriotic tissue samples and eutopic endometrium, as well as 
endometrium from healthy women, focusing on genes involved in inflammation and cellular 
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immunity. After normalization of the raw counts based on the ten housekeeping genes and 
six positive control samples, distinct gene expression between comparisons were visualized 
with the use of heat maps for the following groups: ectopic tissues (ectopic) compared with 
control endometrium (control), eutopic endometrium (eutopic) compared with ectopic, and 
eutopic compared with control. Marker selection analysis with the use of GENE-E was then 
performed to rank all 579 genes from most to least differentially expressed between the 
comparisons, ranking them based on signal-to-noise ratio. The list of genes significantly 
differentially expressed in each comparisons were used to generate KEGG pathways with 
the use of DAVID Bioinformatics resources 6.7 (https://david.ncifcrf.gov/home.jsp). This 
additionally provided GO terms, which were useful in gaining insights into biologic 
processes of the gene clusters that showed statistical significance between comparisons.
Heat Map Analysis Shows that Ectopic Tissue is Uniquely Different from Matched Eutopic 
Endometrium and from Control Endometrium
We first conducted unsupervised hierarchic clustering of 24 samples (eight ectopic, eight 
eutopic, and eight control) on all 579 screened genes (Fig. 1A) to cluster our samples by 
differential expression patterns. As seen by the dendogram, ectopic endometriotic tissues 
completely segregated from both eutopic endometrium and control endometrium tissues, 
suggesting molecular abnormality of endometriotic tissues, even from the molecular profile 
of a patient’s own eutopic endometrium. Surprisingly, the eutopic endometrium from 
patients did not cluster separately from the endometrium of control women. This may be due 
to the menstrual cycle being controlled to the secretory phase. To visualize differentially 
expressed genes further, heat maps were generated by conducting marker selection analysis 
with the use of GENE-E for the following comparisons: ectopic versus control, ectopic 
versus eutopic, and eutopic versus control (Supplemental Fig. 1). This analysis calculated 
the differences in gene expression with the use of test statistics and then estimated the 
significance of the test score. The analysis also corrected for multiple hypotheses testing by 
computing both the false discovery rate (FDR; Q < 0.01) and the familywise error rate 
(FWER). The output of the analysis ranked 579 genes from the most to least differentially 
expressed in each comparison.
Genes Involved in Cytokine–Cytokine Receptor Interaction, Cellular Adhesion, Immune 
Cell Recruitment, and Apoptosis are Significantly Increased in Endometriotic Lesions
First, to profile the molecular differences in the immune and inflammation composition of 
the ectopic endometriotic tissues, we compared the molecular gene profile associated with 
ectopic tissues with that of matched eutopic endometrium and control endometrium samples. 
Compared with the control endometrium samples, the ectopic tissues significantly 
differentially expressed 396 immune and inflammation– related genes out of 579 genes 
screened (Supplemental Table 2). We expected the ectopic lesions to be molecularly 
different, but this number was surprising. Such a large amount of differentially expressed 
genes poses challenges to dissecting out potential biomarkers that could be used as a 
therapeutic strategy. To discern the list of genes that were specific to the ectopic samples, we 
compared the list of significantly differentially expressed genes in ectopic samples to both 
eutopic endometrium and control endometrium (Supplemental Fig. 2). This process 
produced 299 genes that we presumed to be specific to the ectopic samples and as such 
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could be discerned as perhaps “signature genes” for ectopic samples (Fig. 1B). Inputting 299 
genes into the DAVID functional annotation tool generated GO terms including immune 
response, positive regulation of immune system process, defense response, and 
inflammatory response (Supplemental Table 3). Furthermore, 299 genes clustered into 
cellular processes relating to increased lymphocyte and immune system process activation. 
These genes were also involved in KEGG pathways including cytokine-cytokine receptor 
interaction, primary immunodeficiency, cell adhesion molecules, and allograft rejection 
(Supplemental Table 4).
In particular, genes involved in cytokine–cytokine receptor signaling, including IL18, 
IL18R1, IL18RAP, CCL5, CCR2, and S100A8 (Fig. 2A–2F, respectively), and the 
expression of tumor necrosis factor (TNF) superfamily genes, including FAS, TNFRSF1B, 
TNFSF13B, TNFSF8, TNFSF4, TNFSF12, and CD27 (Fig. 2G–2M) were significantly 
increased in ectopic tissues compared with both matched eutopic endometrium from the 
same patients and control endometrium samples. Furthermore, genes associated with cell 
surface markers of immune cells, including CD4, CD45R0, CD8A, CD40, and CD48, (Fig. 
2N–2R), were significantly increased in ectopic tissues compared with both eutopic 
endometrium and control endometrium. Additionally, expression of genes for cell adhesion 
molecules such as ICAM-1 and VCAM-1 were significantly increased in ectopic tissues 
compared with both eutopic endometrium and control endometrial samples (Fig. 2S and T). 
Finally, HLA genes, including HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DRA, and 
HLA-DMA were also significantly increased in expression in ectopic tissues (Fig. 2U–Y).
It is well established that endometriotic lesions recruit endothelial progenitor cells to the site 
to establish its own network of vasculature. Indeed, the expression of CXCL12 and 
PECAM-1, two genes involved in the recruitment of the endothelial progenitor cells and 
other immune cells to the site of damage to promote angiogenesis, were significantly 
increased in ectopic tissues compared with control endometrium (Supplemental Fig. 3A and 
3B). Additionally, prostaglandins are associated with the promotion of pelvic pain in women 
with endometriosis. The gene encoding one of the receptors for prostaglandin E2, PTGER4, 
is significantly increased in the ectopic tissue compared to control endometrium 
(Supplemental Fig. 3C). Furthermore, endometriosis is often referred to as sterile 
inflammation, and recent research has shown involvement of inflammasome complex in the 
pathogenesis of endometriosis (13). Indeed, we were intrigued to find that the genes 
involved in the formation of inflammasome complex, NLRP3 and CASP1, were increased in 
expression in ectopic tissues compared with control endometrium (Supplemental Fig. 3D 
and 3E).
Genes Involved in Natural Killer and T-Cell Cytotoxicity, Cell Signaling, and Regulation of 
Inflammatory Responses are Decreased in Expression in Endometriotic Lesions
Dysfunctional cytotoxicity of natural killer (NK) cells and cytotoxic T cells toward 
endometrial fragments are well documented. Indeed, genes involved in NK cell 
differentiation, cytotoxicity, and recruitment, including NFIL3, GNLY, and IL15, were 
significantly decreased in expression in ectopic tissues compared with control endometrium 
(Fig. 3A–3C). Genes involved in TNF signaling, and mitogen-activated protein kinase 
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signaling pathway, including TRAF4, MAPK1, and DUSP4, were significantly decreased in 
expression in ectopic tissues compared to control endometrium only (Fig. 3D–F). 
Furthermore, two genes involved in the regulation of inflammatory response in immune 
cells, SIGIRR and CEA-CAM-1 were also significantly decreased in ectopic tissues 
compared with both eutopic endometrium and control endometrium.
Genes Involved in Both Classic and Alternate Complement Pathways are Aberrantly 
Expressed in Ectopic Tissues Compared with Control Endometrium Samples
Genes involved in complement pathways were aberrantly expressed in ectopic tissues 
compared with control endometrium. Genes encoding for proteins of classic and alternate 
complement pathways, including C1QA, C1QB, C1R, C1S, C2, C3, C4A/B, C5, C6, C7, 
C8A, CFB, CFH, and CFI (Supplemental Fig. 4A–4N) were significantly increased in 
expression, whereas C4BPA (Supplemental Fig. 4O) was significantly decreased in ectopic 
tissues compared with control samples.
Eutopic Endometrium of Patients Aberrantly Express Genes Involved in Regulation of 
Decidualization, Cellular Adhesion, Cytokine–Cytokine Receptor Interaction, and 
Apoptosis
To gain better understanding of the immune microenvironment in eutopic endometrium 
obtained from endometriosis patients, we also compared the immune transcriptome of 
eutopic endometrium with that of control endometrium from healthy women. Using the 
same approach as above, we found 91 genes out of 579 to be differentially expressed in the 
eutopic endometrium compared with the endometrium of the control subjects (Supplemental 
Table 5). Although distinct differences in the level of expression can be visualized in the 
heat maps comparing ectopic versus eutopic and ectopic versus control, the molecular 
distinction of the eutopic endometrium of patients compared with that of control 
endometrium was not clearly apparent (Supplemental Fig. 1). Nevertheless, a number of 
genes were differentially expressed in the eutopic endometrium. These included genes 
encoding for proinflammatory cytokines, chemokines, and receptors, such as CXCL1, 
CX3CL1, CXCL9, CXCL10, IL32, CXCR2, and IL7R (Supplemental Fig. 5A–5G), as well 
as genes encoding for cell adhesion molecules, such as ICAM3 and SELL (Supplemental 
Fig. 5H and 5I), which were all significantly increased in expression in eutopic endometrium 
of patients compared with control subjects. Furthermore, genes related to allograft rejection, 
including HLA-DPA1, HLA-DPB1, and HLA-DRA, were also significantly increased in 
expression in eutopic endometrium of patients (Supplemental Fig. 5J–5L). Additionally, 31 
genes out of 91 were significantly decreased in expression in eutopic endometrium 
compared with control endometrium. We inputted these genes into DAVID bioinformatics 
resources to assess GO terms. Interestingly, the top five GO terms were related to the 
regulation of apoptosis, programmed cell death, regulation of cell death, regulation of 
cytokine production, and response to wound healing (Supplemental Table 6). The genes 
found in the top five GO terms were BCL6, CD44, SMAD3, CARD9, IKBKG, IL6R, PML, 
and RELA (Fig. 4A–4H), which were significantly decreased in expression in eutopic 
endometrium compared with control endometrium. Additionally, BAX, which encodes for 
the protein that functions with Bcl-2 as a promoter of antiapoptosis, was significantly 
increased in expression in eutopic endometrium compared with control endometrium. Most 
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importantly, eutopic endometrium of patients had significant decrease in NOTCH1 and 
NOTCH2, genes involved in the process of decidualization, compared with control 
endometrium (Fig. 4I–4K).
Eutopic Endometrium Shows Dysregulated Immune Activation Compared with Control 
Endometrium
Genes involved in the complement pathways, including C4A/B, CFB, CFH, and CFI were 
aberrantly expressed in eutopic endometrium of patients compared with control 
endometrium (Supplemental Fig. 6A–6D). In addition to increased expression of genes 
encoding for inflammatory cytokines and chemokines, eutopic endometrium of women with 
endometriosis showed molecular expression characteristics suggesting dysregulation of 
immune cell regulation and cell signaling, especially B-cell signaling. We found that genes 
including NFKBIA, CD19, CD28, CD160, SYK, SLAMF1, SH2D1A, and STAT1 
(Supplemental Fig. 6E–6L) were significantly increased, whereas genes including IKBKAP, 
STAT6, and STAT5B (Supplemental Fig. 6M–6O) were significantly decreased in eutopic 
endometrium compared with control endometrium. The gene expressions for immune cell 
surface markers CD40 and CD48 (Supplemental Figs. 5P and 5Q) were increased in the 
endometrium of patients compared with the control endometrium.
DISCUSSION
Peritoneal inflammation and immune system dysregulation are two key components that 
drive the pathogenesis of endometriosis (9, 16). Earlier studies have reported on the 
contribution of increased concentration of proinflammatory, growth-promoting, and 
angiogenic factors to the pathogenesis of endometriosis (17). Furthermore, aberrant 
activities of the immune system are emphasized in studies that show increased activation of 
macrophages that drive the inflammatory network (18) and suppression of NK cell 
cytotoxicity and differentiation (19, 20) in women with endometriosis. Studies of genome-
wide association (21, 22) and microarrays have been conducted in the hopes of identifying 
nonhormonal therapeutic regimens and identifying biologic pathways relevant to 
endometriosis pathogenesis (23). Those studies, however, focused on illuminating genetic 
susceptibility to endometriosis development or on generalized pathways particularly 
targeting genes regulated by estrogen and progesterone. We conducted our study to fill in the 
gap of knowledge by focusing on the role of inflammation and the immune system in the 
pathogenesis of endometriosis. Specifically, we wanted to dissect the immune 
microenvironment contributing to inflammatory processes in patients with endometriosis to 
aid in finding the answers to pertinent questions regarding disease etiology and 
pathogenesis.
Primarily, ectopic tissues were significantly different in immune gene signatures compared 
with both matched eutopic endometrium and control endometrium. Genes encoding for 
proinflammatory cytokines and receptors were significantly increased in ectopic tissues 
compared with normal endometrial samples. Indeed, increased mRNA expression of IL18 
and its receptors IL18RAP and IL18R1 was reported in adenomyosis patients (24), which 
may suggest an adenomyosis-like invasive phenotype of endometriosis lesions. Additionally, 
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the expression of TNF superfamily genes was significantly increased in ectopic tissues 
compared with both matched eutopic endometrium and control endometrium samples. TNF 
receptor superfamily signaling is involved not only in apoptosis and inflammation, but also 
in pathways associated with proliferation, survival, and differentiation (25, 26). Furthermore, 
increased expression of genes associated with leukocytes, including CD4, CD45R0, CD8A, 
CD3D, CD48, and costimulatory molecules such as CD40, in ectopic tissues suggest that the 
lesions were potentially infiltrated with T cells and antigen-presenting cells. Increased 
expression of HLA genes in ectopic tissues compared with matched eutopic endometrium 
and control endometrium also suggests increased accumulation of antigen-presenting cells in 
ectopic tissues, which express HLA class II molecules on the surface. In addition, expression 
of genes for cell adhesion molecules, such as ICAM-1, VCAM-1, and SELL, were also 
increased, potentially aiding adhesion or invasion of ectopic tissues onto peritoneum or other 
surfaces. Interestingly, in concordance with the recent report by Suryawanshi et al., genes 
encoding for complementary proteins were significantly increased in the ectopic tissues 
compared with the control tissues (27). The contribution of complement proteins toward the 
pathogenesis of endometriosis is unknown; however, we can speculate, from its known 
functions, that they participate not only as a part of immune surveillance system in 
identifying diseased tissues, but also participate in the processes of angiogenesis, 
hematopoietic stem cell mobilization, and regeneration of damaged tissues (28). Not 
surprisingly, we also observed significant increase in PECAM1, CXCL10, and CXCL12 
(genes known to play role in angiogenesis) in ectopic tissues compared with eutopic and 
control endometrium. Indeed, we previously reported increased expression of CXCL12 
protein in human endometriotic lesions compared with matched eutopic endometrium 
samples and demonstrated that blocking of CXCL12 in a xenograft mouse model of 
endometriosis affects neovascularization and survival of endometriotic lesions (29). To this 
end, these immune gene profiles further support that ectopic endometriotic lesion is viewed 
as foreign, elicits local inflammation, establishes vasculatures, and participates in the 
generation of pain for some patients, as suggested by increased PTGER4 expression in 
ectopic tissues.
We also observed that the genes involved in regulation of inflammation, NK and cytotoxic T-
cell activity, and cellular apoptosis are aberrantly expressed in the ectopic tissues. This is not 
surprising as endometriosis is associated with peritoneal inflammation. Currently, it is 
unknown whether women that develop endometriosis inherently harbor a proinflammatory 
peritoneal microenvironment or it is the presence of the disease that leads to the 
inflammatory milieu. What was interesting was to find that two novel genes previously 
unrelated to endometriosis, SIGIRR and CEACAM-1, were significantly decreased in 
expression in ectopic tissues compared with control tissues. Mice deficient in SIGIRR gene 
showed enhanced inflammatory response following interleukin (IL) 1 injection and showed 
increased response to certain Toll ligands (30). Furthermore, a recent study demonstrated the 
role of CEACAM-1 protein in protumor activity and that T cells deficient in CEACAM-1 
gene are hyperinflammatory in nature, leading to severe experimental colitis in mice (31). 
Consequently, decreased expression of both SIGIRR and CEACAM-1 genes in ectopic 
tissues may explain the dysregulated inflammatory cytokine elevation and T-cell activation 
observed in endometriosis patients. Furthermore, decreased expression of NFIL3 (32), IL15 
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(33), and GNLY (34) in ectopic lesions support diminished cytotoxicity of NK and CD8+ T 
cells in women with endometriosis toward autologous endometrial fragments (35, 36). The 
expression of genes involved in signaling pathways, including TRAF4, MAPK1, and 
DUSP4, were significantly decreased in expression in ectopic tissues compared with control 
endometrium. These genes may be involved in the regulation of cellular proliferation and 
apoptosis, and may aid in the survival of the endometriotic fragments in ectopic locations.
Interestingly, gene expression of FAS, which encodes for FAS, or death, receptor, was 
significantly increased in ectopic tissues compared with disease-free endometrium. The 
significant elevation of FAS in ectopic tissues contradicts a recent study that showed, by 
means of immunohistochemistry, decreased FAS expression in the epithelial cells of ectopic 
tissues (37). As such, we attribute increased FAS expression to the resident immune cells, 
which are likely subjected to apoptosis by increased FasL in the peritoneal fluid of 
endometriosis patients (38). Overall, our data characterize endometriosis as a disease where 
many biologic and immune-related pathways are dysregulated.
We previously reported the potential involvement of IL-17A in the pathogenesis of 
endometriosis (39) and speculated that TH17 cells, or other cells of immune system with the 
capacity to produce IL-17A, must be contributing to the recruitment of proinflammatory 
immune cells into the peritoneal cavity. Interestingly, in the present study, we observed that 
the gene expression of RORC, which encodes for the transcription factor RORγt that 
determines TH17 lineage from naïve CD4+ T cells, was significantly decreased in ectopic 
tissues compared with disease-free endometrium (Supplemental Fig. 7A). RORC expression 
was also decreased in the matched eutopic endometrium of patients compared with the 
disease-free endometrium (Supplemental Fig. 7B). However, expression of IL-17A, which 
encodes for the main effector cytokine IL-17A, was significantly increased in the ectopic 
tissues and in the matched eutopic endometrium of patients compared with the disease-free 
endometrium (Supplemental Fig. 7C and 7D). These data suggest the involvement of other 
immune cell subtypes that express IL-17A and potentially participate in the promotion of 
inflammation.
To further contribute to the growing evidence showing molecular differences inherent in 
endometrium of women with endometriosis (40), we compared the gene expression of 
eutopic endometrium of patients with the expression profile obtained from the endometrium 
of healthy control subjects. As previously reported (41), genes encoding for cell adhesion 
molecules, including ICAM3 and SELL, were significantly increased in expression in the 
eutopic endometrium of patients compared with control subjects, which supports their 
enhanced capacity to adhere to the mesothelium. We also observed increased gene 
expression of innate immune cell chemotactic factors such as CXCL1, CXCL9, and 
CXCL10. However, it was interesting to find increased gene expression of CD40 and CD48, 
which are costimulatory molecules used by antigen-presenting cells to activate T and B cells 
(42). Additionally, we found increased B-cell activation–related genes, including SYK, 
SH2D1A, SLAMF1, and CD19, in eutopic endometrium compared with control. Increased 
expression of SYK, SH2D1A, and SLAMF1 is especially intriguing, because SYK plays a 
role in autoimmune disease development, and SH2D1A and SLAMF1 are implicated in T-
cell differentiation and function and regulation of T-cell–dependent B-cell activation, 
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respectively (43, 44). In particular, the proteins encoded by SLAMF1 and SH2D1A, CD150 
and SAP, interact to promote differentiation of TH17 and TC17 cells and have been shown to 
contribute to the pathogenesis of autoimmunity in experimental autoimmune 
encephalomyelitis (45). Furthermore, interesting B-cell signaling is shown in eutopic 
endometrium of patients by increased expression of CD40 and SYK and decreased 
expression of BCL6. Down-regulation of BCL6 expression by CD40 signaling has been 
documented in B-cell lymphoma (46). Abnormal B-cell activity in eutopic endometrium of 
patients, as suggested by our data, further substantiates endometriosis as an autoimmune 
disease.
We also observed significant increase in HLA genes in the eutopic endometrium compared 
with the control endometrium, which may confer the ability to escape immune surveillance 
to the exuded endometrial fragments in the peritoneal cavity (47). Specifically, HLA-DP 
proteins are perhaps of importance because they are expressed on activated antigen-
presenting cells and function as peptide-antigen presentation elements to CD4+ T cells (48). 
Increased expression of certain HLA genes may also contribute to the theory of 
endometriosis as autoimmune disease (12), and potentially explain the mechanism behind 
how fragments may escape the immune surveillance.
Furthermore, the eutopic endometrium of patients showed diminished spontaneous apoptosis 
compared with the endometrium from women without disease (49), and increased 
expression of antiapoptotic genes in the eutopic endometrium from patients has been 
previously reported (50). Here, we also observed that BAX, a gene encoding for the protein 
that functions with Bcl-2 as a promoter of antiapoptosis, was increased in the eutopic 
endometrium compared with control. Such gene expression profile presents eutopic 
endometrium of patients as a curious entity infiltrated with activated T, B, and dendritic cells 
with increased capacity for cellular adhesion and diminished potential for apoptosis with the 
ability to evade immune surveillance. Our study is unique regarding the nature of the patient 
cohort, consisting of those diagnosed with infertility, which may explain the decreased gene 
expression of notch signaling molecules, NOTCH1 and NOTCH2, in endometrium of 
patients compared with disease-free endometrium of control subjects. Our observation 
supports previous findings (51) that linked diminished notch signaling to defective 
endometrium decidualization in endometriosis patients.
Recent research into the infertility associated with endometriosis patients revealed that 
eutopic endometrium of patients is molecularly different compared with the endometrium of 
healthy control subjects. Indeed, women with endometriosis exhibit menstrual cycle 
irregularities and their endometria have diminished ability of decidualization (40). Our data 
suggests that once an endometrial fragment is exteriorized into the peritoneal cavity, it 
becomes pathogenic by undergoing molecular changes. It is still unknown whether the 
peritoneal inflammatory milieu is an inherent feature of women with endometriosis, or the 
presence of endometrial fragments initiates sterile inflammation that triggers endometriosis 
development. Clearly, aberrant molecular features of the eutopic endometrium may play a 
mechanistic role toward the formation of endometriotic lesions in the peritoneal cavity. By 
means of cDNA microarray technology and microdissection with the use of 9,600 genes/
expressed sequence tags, Wu et al. (52) profiled gene expression differences between 
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ovarian endometrioma and eutopic endometria from 12 women adjusted for menstrual 
phase. Despite the belief that ectopic lesions arise from the patient’s own eutopic 
endometrium, the researchers were surprised to find significant transcriptional differences 
between what used to be the same tissue in different locations. We also found in our study 
that out of 579 genes, 322 genes were significantly differentially expressed when eutopic 
endometrium was compared with ectopic tissues. Undoubtedly, the endometrium of infertile 
women with endometriosis, which is molecularly different from that of healthy control 
subjects, undergoes further changes in the peritoneal cavity that transform it to an 
endometriotic lesion.
CONCLUSION
One of the important limitations of this study is the use of whole-tissue lysates to discern 
immune dysfunction and inflammation in women with endometriosis. An endometriotic 
tissue contains myriads of both innate and adoptive immune cells that are actively 
participating in peritoneal inflammation and lesion establishment. Besides, an endometriotic 
lesion is composed of complex epithelial, stromal, and endothelial cells known to respond 
distinctly to hormonal stimuli. To truly investigate the immune aspect of pathophysiology, 
we need to isolate the infiltrating immune cells and compare the differences in their 
activation status between the disease and control cohorts. This task is challenging and to our 
knowledge has not been attempted as of yet. We partially addressed this aspect by consulting 
a paper on immune response in silico (53) that elegantly compiled a list of markers specific 
to immune cells, which can be used to study the immune component from nonimmune 
tissues. That article demonstrated that the means of identifying immune-specific markers 
from nonimmune tissues, such as endometriotic lesions or endometrium, are not impossible 
if we use the markers that are specific to immunity.
Another important issue that needs to be considered is the complexity of endometriosis in 
terms of stage and type of the disease, pain, age of the individual, and the impact of 
hormonal interventions on the disease state. The disease can definitely be diagnosed and 
staged with the use of surgery, adding further complexity to establishing true control 
samples. For these reasons, the pathophysiology of endometriosis remains elusive. 
Furthermore, our study specifically focused on the secretory phase of endometrium. To fully 
map out the course of endometriosis development throughout the menstrual cycle, we need 
to analyze tissue samples from both proliferative and secretary phases of the menstrual cycle 
to determine whether the differences in immune gene profiles are influenced by the 
menstrual stage/hormones. Finally, low sample numbers used in the study did not permit us 
to differentiate between the specific disease phenotype (ovarian endometriosis and deep 
infiltrating endometriosis). Therefore the conclusions derived from the findings of this study 
are restricted to endometriosis patients with infertility related problems.
To this end, the present study, for the first time to our knowledge, provides a molecular 
profile of ectopic endometriotic lesions compared with the matched eutopic tissues and 
control endometrium focused on genes involved in inflammation and the immune system. 
We show aberrant transcription of genes involved in decidualization of endometrium, which 
may explain why our endometriosis patients were referred for infertility-related problems. 
Ahn et al. Page 12
Fertil Steril. Author manuscript; available in PMC 2017 November 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fundamentally, our data provide critical insights into why endometrial fragments of women 
with endometriosis are able to implant, proliferate, establish localized blood supply, and 
elicit inflammatory stimulus. Our data also provide explanation, evident from molecular 
profiling, of why endometrial fragments of women with endometriosis are able to implant, 
proliferate, establish localized blood supply, and elicit inflammatory stimulus. Indeed, our 
data validate the presence of immune dysregulation often observed in the peritoneal fluid of 
women with endometriosis, and further emphasize the importance of using immune gene 
expression profiles as a guide to better define all the facets that contribute to the 
pathogenesis of endometriosis.
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FIGURE 1. 
Unsupervised hierarchic clustering of 24 samples with the use of GENE-E software for 579 
inflammation and immune-related genes. Ectopic endometrium (n = 8), eutopic 
endometrium (n = 8), and control endometrium samples (n = 8) were subjected to 
unsupervised hierarchical clustering analysis for (A) all 579 analyzed genes followed by (B) 
the same analysis using 299 selected genes to assess differential expression of 
transcriptomics in each group. The dendogram on the right-hand side shows complete 
segregation of the ectopic endometriotic samples (ectopic 1–8) from the eutopic 
endometrium (eutopic 1–8) and control endometrium tissue samples (control 1–8). The list 
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of significantly differentially expressed genes for ectopic versus control (396 genes 
significantly differentially expressed) and ectopic versus eutopic (322 genes significantly 
differentially expressed) were further compared to identify transcriptomes that were 
differentially measured in ectopic endometriotic tissues only. This led to the identification of 
299 genes that were commonly differentially expressed in transcript counts in the ectopic 
endometriotic tissue sample (B). The color scale bar denotes maximum counts in red and 
minimal counts in blue.
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FIGURE 2. 
Representative immune genes were significantly increased in ectopic endometriotic lesions. 
The expression of genes encoding for (A–F) inflammatory cytokines and receptors, (G) 
receptor for FAS, (H–L) TNF superfamily, (M–R) cell surface markers for T-cell activation 
and antigen-presenting cell activation, (P and Q) chemoattractants for endothelial progenitor 
cell recruitment, (S and T) cell adhesion molecules, and (U–Y) HLA molecules were 
significantly increased in the ectopic tissues compared with the control. The graphs 
represent the scatter plots of all samples. The middle bar denotes the mean of the samples, 
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and the error bars represent the standard deviation. *P≤.05 between ectopic versus eutopic 
and between ectopic versus control.
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FIGURE 3. 
Representative immune genes were significantly decreased in ectopic endometriotic lesions 
compared with matched eutopic endometrium. Genes involved in (A–C) the regulation of 
natural killer and cytotoxic T-cell activity and (D–F) the cell signaling mechanism for 
proliferation and apoptosis were significantly decreased in expression in ectopic tissues 
compared with control. The expression of genes involved in the regulation of T-cell activity 
and inflammation were significantly decreased in ectopic tissues compared with control (G 
and H). The graphs represent scatter plots of all samples. *P≤.05 between ectopic versus 
eutopic and between ectopic versus control.
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FIGURE 4. 
Genes involved in the cell signaling pathway for apoptosis and cell death were significantly 
decreased in the eutopic endometrium. Genes involved in (A–H) the apoptosis and cell death 
signaling pathway and (J and K) decidualization were significantly decreased in eutopic 
endometrium compared with control. (I) BAX, a gene encoding for a protein involved in 
apoptosis, was significantly increased in eutopic endometrium compared with control. *P≤.
05.
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